AGTR1 and diabetes mellitus: Activation of AngII/AT1R pathway in the setting of diabetes can in fact promote cell growth and proliferation, apoptosis [162], oxidative stress generation [9], inflammation [6], and fibrosis [9], which are all leading to cardiac remodeling and atherosclerosis, that can be reversed/reduced by RAAS blockade [7–9].